0001213900-17-011589.txt : 20171108
0001213900-17-011589.hdr.sgml : 20171108
20171108161521
ACCESSION NUMBER: 0001213900-17-011589
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20171108
DATE AS OF CHANGE: 20171108
EFFECTIVENESS DATE: 20171108
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-298360
FILM NUMBER: 171186788
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
D
1
primary_doc.xml
X0708
D
LIVE
0000812796
SOLIGENIX, INC.
29 EMMONS DRIVE
SUITE C-10
PRINCETON
NJ
NEW JERSEY
08540
609-538-8200
DELAWARE
Immunotherapeutics Inc.
Endorex Corp.
Dor BioPharma Inc.
DOR BIOPHARMA INC
ENDOREX CORP
IMMUNOTHERAPEUTICS INC
Corporation
true
Christopher
J.
Schaber, PhD
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Executive Officer
Director
Keith
L.
Brownlie, CPA
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Director
Marco
M.
Brughera, DVM
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Director
Gregg
A.
LaPointe, CPA
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Director
Robert
J.
Rubin, MD
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Director
Jerome
B.
Zeldis, PhD
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Director
R.
Christopher
Cavalli, PhD
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Executive Officer
Oreola
Donini, PhD
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Executive Officer
Karen
Krumeich
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Executive Officer
Adam
T.
Rumage
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Executive Officer
Richard
C.
Straube, MD MSc
29 Emmons Drive, Suite C-10
Princeton
NJ
NEW JERSEY
08540
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2017-11-02
false
true
false
0
Aegis Capital Corp.
15007
None
None
801 7TH AVE., 18TH AND 22ND FLOOR
NEW YORK
NY
NEW YORK
10019
CA
CALIFORNIA
NY
NEW YORK
PA
PENNSYLVANIA
false
1964000
1964000
0
false
6
0
137480
Additionally, the Issuer agreed to (i) sell, for the price of $100, the placement agent a warrant to purchase 19,640 shares of common stock at a price of $2.50 per share and (iii) reimburse certain expenses of the placement agent.
0
false
SOLIGENIX, INC.
/s/ Christopher J. Schaber
Christopher J. Schaber, Ph.D
President and Chief Executive Officer
2017-11-07